Logo image of ALBIZ.PA

OBIZ SA (ALBIZ.PA) Stock Fundamental Analysis

EPA:ALBIZ - Euronext Paris - Matif - FR0014003711 - Common Stock - Currency: EUR

3.78  -0.01 (-0.26%)

Fundamental Rating

3

Taking everything into account, ALBIZ scores 3 out of 10 in our fundamental rating. ALBIZ was compared to 65 industry peers in the Media industry. While ALBIZ seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, ALBIZ is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALBIZ has reported negative net income.
ALBIZ had a positive operating cash flow in the past year.
In multiple years ALBIZ reported negative net income over the last 5 years.
ALBIZ had a positive operating cash flow in 4 of the past 5 years.
ALBIZ.PA Yearly Net Income VS EBIT VS OCF VS FCFALBIZ.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 1M -1M 2M -2M

1.2 Ratios

With a Return On Assets value of -4.69%, ALBIZ is not doing good in the industry: 75.38% of the companies in the same industry are doing better.
With a Return On Equity value of -21.64%, ALBIZ is not doing good in the industry: 75.38% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -4.69%
ROE -21.64%
ROIC N/A
ROA(3y)-1.35%
ROA(5y)-1.29%
ROE(3y)-6.63%
ROE(5y)-2.64%
ROIC(3y)N/A
ROIC(5y)N/A
ALBIZ.PA Yearly ROA, ROE, ROICALBIZ.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

ALBIZ has a worse Gross Margin (13.37%) than 86.15% of its industry peers.
ALBIZ's Gross Margin has declined in the last couple of years.
ALBIZ does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 13.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.72%
GM growth 5Y-18.3%
ALBIZ.PA Yearly Profit, Operating, Gross MarginsALBIZ.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

ALBIZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALBIZ has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ALBIZ has been increased compared to 5 years ago.
Compared to 1 year ago, ALBIZ has an improved debt to assets ratio.
ALBIZ.PA Yearly Shares OutstandingALBIZ.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ALBIZ.PA Yearly Total Debt VS Total AssetsALBIZ.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 2.81 indicates that ALBIZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
With an excellent Altman-Z score value of 2.81, ALBIZ belongs to the best of the industry, outperforming 90.77% of the companies in the same industry.
A Debt/Equity ratio of 1.70 is on the high side and indicates that ALBIZ has dependencies on debt financing.
ALBIZ has a Debt to Equity ratio of 1.70. This is in the lower half of the industry: ALBIZ underperforms 75.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF N/A
Altman-Z 2.81
ROIC/WACCN/A
WACC5.92%
ALBIZ.PA Yearly LT Debt VS Equity VS FCFALBIZ.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 2.17 indicates that ALBIZ has no problem at all paying its short term obligations.
ALBIZ has a better Current ratio (2.17) than 92.31% of its industry peers.
ALBIZ has a Quick Ratio of 1.90. This is a normal value and indicates that ALBIZ is financially healthy and should not expect problems in meeting its short term obligations.
ALBIZ has a Quick ratio of 1.90. This is amongst the best in the industry. ALBIZ outperforms 90.77% of its industry peers.
Industry RankSector Rank
Current Ratio 2.17
Quick Ratio 1.9
ALBIZ.PA Yearly Current Assets VS Current LiabilitesALBIZ.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for ALBIZ have decreased strongly by -2780.72% in the last year.
ALBIZ shows a strong growth in Revenue. In the last year, the Revenue has grown by 51.46%.
Measured over the past years, ALBIZ shows a very strong growth in Revenue. The Revenue has been growing by 67.67% on average per year.
EPS 1Y (TTM)-2780.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2710.29%
Revenue 1Y (TTM)51.46%
Revenue growth 3Y50.48%
Revenue growth 5Y67.67%
Sales Q2Q%5.73%

3.2 Future

ALBIZ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 292.43% yearly.
The Revenue is expected to grow by 6.63% on average over the next years.
EPS Next Y920%
EPS Next 2Y292.43%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.07%
Revenue Next 2Y7.33%
Revenue Next 3Y6.33%
Revenue Next 5Y6.63%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALBIZ.PA Yearly Revenue VS EstimatesALBIZ.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
ALBIZ.PA Yearly EPS VS EstimatesALBIZ.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 0.1 0.2 0.3

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALBIZ. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 14.39, which indicates a correct valuation of ALBIZ.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALBIZ is on the same level as its industry peers.
ALBIZ is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 14.39
ALBIZ.PA Price Earnings VS Forward Price EarningsALBIZ.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALBIZ indicates a slightly more expensive valuation: ALBIZ is more expensive than 69.23% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.42
ALBIZ.PA Per share dataALBIZ.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

ALBIZ's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALBIZ's earnings are expected to grow with 292.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y292.43%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALBIZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OBIZ SA

EPA:ALBIZ (7/21/2025, 7:00:00 PM)

3.78

-0.01 (-0.26%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.71%
Inst Owner ChangeN/A
Ins Owners53.65%
Ins Owner ChangeN/A
Market Cap22.19M
Analysts87.27
Price Target8.3 (119.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-17.85%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.39
P/S 0.18
P/FCF N/A
P/OCF 21.26
P/B 1.85
P/tB N/A
EV/EBITDA 17.42
EPS(TTM)-0.44
EYN/A
EPS(NY)0.26
Fwd EY6.95%
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)0.18
OCFY4.7%
SpS21.44
BVpS2.04
TBVpS-2.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.69%
ROE -21.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 13.37%
FCFM N/A
ROA(3y)-1.35%
ROA(5y)-1.29%
ROE(3y)-6.63%
ROE(5y)-2.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.72%
GM growth 5Y-18.3%
F-Score4
Asset Turnover2.28
Health
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF N/A
Debt/EBITDA 9.61
Cap/Depr 119.21%
Cap/Sales 2.2%
Interest Coverage N/A
Cash Conversion 49.18%
Profit Quality N/A
Current Ratio 2.17
Quick Ratio 1.9
Altman-Z 2.81
F-Score4
WACC5.92%
ROIC/WACCN/A
Cap/Depr(3y)85.83%
Cap/Depr(5y)92.26%
Cap/Sales(3y)2.18%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2780.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2710.29%
EPS Next Y920%
EPS Next 2Y292.43%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)51.46%
Revenue growth 3Y50.48%
Revenue growth 5Y67.67%
Sales Q2Q%5.73%
Revenue Next Year8.07%
Revenue Next 2Y7.33%
Revenue Next 3Y6.33%
Revenue Next 5Y6.63%
EBIT growth 1Y-120.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year209.24%
EBIT Next 3Y91.94%
EBIT Next 5Y57.12%
FCF growth 1Y-434.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.6%
OCF growth 3YN/A
OCF growth 5Y4.44%